Insulin Syringe Units for Peptide Dosing: mcg to Units Chart

How Do You Know If a Peptide Supplier Is Trustworthy?

Check for three things before you buy. First, get a batch-specific Certificate of Analysis (COA) from an independent lab, not the manufacturer's own lab. Second, look for HPLC and mass spectrometry data showing purity above 98%. Third, check endotoxin testing results. A 2018 forensic study found some seized peptide products tested as low as 5% pure. Verification is not optional.

Most buyers never open the COA past the purity percentage on the front page. That single number tells you almost nothing on its own. A supplier can print "99% purity" on a label. But it can still be selling something with the wrong amino acid sequence. This happens because purity testing and identity testing are two different processes. One tells you how much of the sample is a single compound. The other tells you whether that compound is really the peptide named on the vial. You need both. And you need them from a lab that has no financial stake in the result.

What Should a Real Third-Party COA Actually Show?

A batch number is the detail most fake COAs skip. If the same PDF shows up attached to five different product listings across a supplier's site, it was not run on your vial. Ask the supplier to match the lot number printed on your product to the lot number on the document. A legitimate operation does this without hesitation, because it costs them nothing and it is the entire point of the paperwork.

What Common Counterfeits and Substitutions Show Up in Testing?

Forensic labs keep finding the same handful of problems repeated across gray market peptide products. A 2018 Belgian analysis looked at ten frequently seized peptide drugs. These included growth hormone secretagogues and wound-healing peptides. Purity ranged from just 5% to 75% for cysteine-containing compounds. The analysis also found arsenic and lead at levels up to ten times the safety limit for injectable drugs (Janvier et al. 2018). None of that shows up on a visual inspection of the vial. The powder looks identical whether it is 95% pure or 20% filler.

A separate 2024 investigation looked at online semaglutide sellers. Sellers claimed 99% purity, but actual peptide content ranged from 7.7% to 14.37%. Every single sample tested positive for bacterial endotoxin (Ashraf et al. 2024). Endotoxin is a byproduct of bacterial contamination during manufacturing. When injected into the body, it can trigger fever and inflammation. This has nothing to do with the peptide itself. A broader review of gray market peptide use flags mislabeling and undisclosed substitution too. These are recurring, structural risks. The supply chain has no mandatory testing checkpoint (unregulated peptide review, 2026).

Trusted Sourcing vs. Unverified Sourcing: A Side-by-Side Look

Price is the tell most people ignore. Real peptide synthesis and third-party testing cost money. A vial priced dramatically under every comparable listing usually means one of the testing steps got skipped, not that you found a deal.

Which Lab Methods Actually Verify a Peptide's Identity and Purity?

Three tests matter, and each one answers a different question.

HPLC, meaning high-performance liquid chromatography, separates a sample into its parts. It measures what fraction is the target compound versus impurities. It is the standard purity test. But it cannot tell you the compound's exact identity on its own. Mass spectrometry (MS) measures the molecular weight of the compound. This confirms it is actually the peptide named on the label, not something structurally close. A peptide can pass an HPLC purity check and still fail an MS identity check if the underlying molecule is wrong.

Endotoxin testing, often called an LAL test, checks specifically for bacterial contamination. HPLC and MS do not detect this at all. A peptide can be 99% chemically pure and still carry endotoxin levels that cause a reaction on injection. Some higher-end labs also run quantitative nuclear magnetic resonance (qNMR). This test gives a full structural fingerprint of the molecule, compared against a reference standard. It is expensive. That is exactly why gray market sellers almost never provide it.

How Often Do Gray Market Peptides Actually Fail Testing?

Not rarely. The Belgian forensic study cited above screened products because they were among the most frequently seized on that market. It still found purity failures across most samples tested (Janvier et al. 2018). This is not a fringe risk limited to obscure sellers. It is a pattern that shows up whenever independent labs, rather than the sellers themselves, run the tests.

Purity also matters more for some compounds than others. BPC-157 clears the body fast. Its plasma half-life, meaning how long it stays active before the body breaks it down, is under 30 minutes. The liver and kidneys clear it quickly (Vasireddi et al. 2025). A fast-clearing compound gives you less room to absorb dosing error. An underfilled or diluted vial has no buffer window. A slightly wrong amount does not even out over time.

What Questions Should You Ask a Supplier Before You Buy?

• Can you provide a COA matched to this specific batch or lot number, not a generic template?
• Which lab ran the testing, and is it independent of your company?
• Does the COA include mass spectrometry data? Or does it only show an HPLC purity percentage?
• Was endotoxin testing performed, and what were the results?
• How is the product stored and shipped to preserve stability before it reaches me?

A supplier that answers all five without hesitation has almost certainly done the work. One that gets vague, redirects, or only offers a general-purpose purity statement has usually skipped a step somewhere in that chain.

Does a Low Price Always Mean Low Quality?

Not always, but it is the single strongest warning sign available to someone without lab access. Legitimate synthesis, third-party testing, and proper cold-chain shipping all cost money. That cost shows up in the final price. A listing priced far below every comparable competitor is telling you something got cut. Testing is usually the first corner cut, because it is invisible to the buyer until something goes wrong.

This is also where the sportsman's instinct for cutting corners under fatigue works against you here. Nobody skips a warm-up because they think it is safe; they skip it because the cost feels invisible until the injury shows up. A cheap, untested vial works the same way. The consequence does not show up on day one.

How Does This Fit Into the Bigger Picture on Peptide Regulation?

The gray market exists because peptide regulation in the United States is inconsistent and shifting. Some compounds sit in a legal gray zone. This zone changes as agencies revisit their classifications. That is part of why sourcing verification matters more here than with a standard supplement purchase. If you want the fuller regulatory picture, see our breakdown of what FDA reclassification actually means. Our piece on the wider peptide purity crisis also covers how that uncertainty shapes what ends up in a vial. For a step-by-step checklist beyond what is covered here, see our full guide on how to vet a peptide supplier.

This content is for educational purposes only. These compounds are intended for research use. Nothing here is medical advice, and any decision involving your health should involve a qualified clinician.

Where Does Sourcing Fit With Dosing and Reconstitution?

Verification comes before calculation.

A perfectly accurate mcg-to-unit conversion is meaningless if the vial itself is underfilled or mislabeled. First, confirm a batch-specific COA and independent lab testing. Then the reconstitution math in our reconstitution concentration chart and dosing references like the BPC-157 dosage chart actually mean something. They assume the label matches the vial. Reliable sourcing matters for your whole research plan. Check our recommended sources page before you pick a vendor.

Frequently Asked Questions